| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥269.4B | ¥273.6B | -1.5% |
| Operating Income | ¥25.9B | ¥19.2B | +35.0% |
| Ordinary Income | ¥28.6B | ¥22.0B | +29.9% |
| Net Income | ¥22.5B | ¥14.6B | +54.0% |
| ROE | 5.7% | 3.9% | - |
FY2025 Q3 cumulative results show revenue of 26.9B yen (YoY -1.5%), operating income of 2.6B yen (+35.0%), ordinary income of 2.9B yen (+29.9%), and net income of 2.3B yen (+54.0%). While topline remained essentially flat, profitability improved substantially across all profit levels. Operating margin expanded to 9.6% from 7.0% in the prior year period, driven by gross margin maintenance and controlled selling, general and administrative expenses. Net profit margin reached 8.4%, up from 5.3% YoY, though this includes non-recurring gains from investment securities sales of 663M yen. Total assets increased to 59.3B yen from 53.0B yen, while equity strengthened to 39.3B yen from 37.5B yen, reflecting improved profitability and comprehensive income gains.
Revenue of 26.9B yen declined 1.5% YoY, with the Chemistry segment contributing 15.3B yen (down 3.5% YoY), Metal Working 5.5B yen (up 2.5% YoY), Bottling 3.4B yen (down 2.0% YoY), and Engineering Services 2.7B yen (up 3.2% YoY). Chemistry remains the core business, representing approximately 57% of total sales. The modest revenue contraction reflects market conditions affecting the Chemistry segment, partially offset by growth in Metal Working and Engineering Services.
Operating profit improved 35.0% to 2.6B yen despite the revenue decline, indicating significant operational efficiency gains. Gross profit of 7.1B yen yielded a gross margin of 26.2%, while SG&A expenses were controlled at 4.5B yen. This resulted in an operating margin of 9.6%, up 2.6 percentage points YoY. Segment operating income showed strong performance across all divisions: Chemistry 1.4B yen (up 60.8% YoY), Engineering Services 641M yen (up 45.0% YoY), Metal Working 503M yen (up 30.3% YoY), and Bottling 210M yen (down 9.9% YoY). The Chemistry segment's profitability recovery was particularly notable given its revenue decline, suggesting improved cost structure. A non-recurring factor of 121M yen impairment loss was recorded in the silicon wafer business within the Chemistry segment.
Ordinary income of 2.9B yen increased 29.9% YoY, reflecting non-operating net income of approximately 270M yen above operating income. Financial income including dividends and equity method gains contributed to this non-operating improvement. Net income of 2.3B yen grew 54.0%, accelerating beyond ordinary income growth due to extraordinary gains. Investment securities sales generated 663M yen in gains, contributing approximately 490M yen after-tax equivalent. This non-recurring contribution explains the material gap between ordinary income growth of 29.9% and net income growth of 54.0%. Comprehensive income reached 4.0B yen, substantially exceeding net income due to 1.7B yen in other comprehensive income, primarily from securities valuation gains.
This represents a revenue decline with profit growth pattern, driven by operational improvements and enhanced capital efficiency in core segments, supplemented by non-recurring investment gains.
Chemistry generated revenue of 16.1B yen and operating income of 1.4B yen, representing the largest segment with approximately 60% of total external sales and 51% of segment operating income. Operating margin for Chemistry was 8.6%, improving significantly from 5.3% in the prior year period. This segment is the core business and its margin recovery despite revenue decline indicates successful restructuring or cost optimization. However, the 121M yen impairment loss in the silicon wafer business signals challenges in this sub-segment that warrant monitoring.
Engineering Services contributed revenue of 4.1B yen and operating income of 641M yen, achieving an operating margin of 15.7%, the highest among all segments. This represents 45.0% YoY growth in operating income on modest revenue expansion, demonstrating strong leverage and pricing power. The segment's margin profile substantially exceeds other divisions.
Metal Working recorded revenue of 5.6B yen and operating income of 503M yen, yielding an operating margin of 9.0%. Both revenue and profit grew steadily, with operating income up 30.3% YoY, indicating solid demand and operational execution in this segment.
Bottling generated revenue of 3.4B yen and operating income of 210M yen, with an operating margin of 6.2%. This segment experienced the only profit decline among divisions, with operating income down 9.9% YoY despite modest revenue contraction of 2.0%, suggesting margin compression that requires attention.
Material margin differences exist across segments, with Engineering Services achieving 15.7% versus Bottling at 6.2%, a 9.5 percentage point spread. This suggests different competitive dynamics and value propositions across the portfolio.
[Profitability] ROE of 5.7% remains below the company's sustainable target level but improved from prior periods given net income growth of 54.0%. Operating margin of 9.6% expanded 2.6 percentage points from 7.0% YoY, reflecting operational efficiency gains. Net profit margin reached 8.4%, up from 5.3% YoY, though this includes non-recurring investment gains. Gross margin of 26.2% was maintained despite revenue pressure. ROIC of 4.6% remains at levels warranting improvement for capital efficiency. [Cash Quality] Cash and deposits totaled 4.5B yen, providing coverage of 1.5 times against short-term debt of 3.0B yen. Interest coverage ratio of approximately 70 times indicates ample capacity to service debt obligations, with interest expense of only 37M yen against operating income of 2.6B yen. [Investment Efficiency] Asset turnover of 0.455 reflects capital-intensive manufacturing operations but remains below optimal levels, indicating room for improved asset utilization. Fixed assets of 22.6B yen represent 38.2% of total assets, with construction in progress of 2.9B yen suggesting ongoing capital investment. Intangible assets increased 56.5% to 751M yen, reflecting investment in software and rights. Investment securities grew 26.9% to 11.0B yen, representing 18.5% of total assets. [Financial Health] Equity ratio of 66.3% provides a strong capital foundation, up from 70.7% in the prior period. Current ratio of 163.0% and quick ratio of 136.0% indicate healthy liquidity positions. Debt-to-equity ratio of 0.51 remains conservative. However, short-term liabilities represent 98.1% of total debt, creating refinancing concentration risk despite low absolute debt levels of 3.1B yen in interest-bearing obligations.
Cash flow statement details are not disclosed for the quarterly period, requiring balance sheet analysis of fund movements. Cash and deposits increased 3.3B yen YoY to 4.5B yen, representing 73% growth and indicating substantial cash accumulation. Operating profit growth of 35% contributed to this cash generation, though net income growth of 54% includes non-cash investment security gains. Total assets expanded 11.8% to 59.3B yen, primarily driven by investment securities increasing 2.3B yen and intangible assets rising 271M yen, suggesting deployment of funds toward strategic investments. Trade receivables increased 500M yen or 4.3%, marginally outpacing the revenue decline of 1.5%, indicating some extension in collection cycles. Inventories grew 1.4B yen or 14.3% to 11.2B yen, materially exceeding revenue trends and raising working capital efficiency concerns. Trade payables increased 100M yen or 1.8% to 5.8B yen, growing slower than inventory buildup. Working capital absorption from inventory growth represents a use of cash that partially offset operating improvements. Short-term borrowings remained stable at 3.0B yen while long-term debt declined 75% to 59M yen, demonstrating deleveraging in the capital structure. Investment securities holdings expanded significantly alongside cash accumulation, suggesting capital allocation toward financial assets. The cash coverage of 1.5 times short-term liabilities indicates adequate near-term liquidity, though the 98% concentration of debt in short-term maturities requires ongoing refinancing attention. Comprehensive income of 4.0B yen exceeded net income by 1.7B yen due to valuation gains, representing unrealized appreciation that strengthens the balance sheet but does not constitute cash generation.
Ordinary income of 2.9B yen versus operating income of 2.6B yen shows non-operating net contribution of approximately 270M yen, representing 1.0% of revenue. This comprises primarily financial income and equity method investment gains as core components. Net income of 2.3B yen compared to ordinary income of 2.9B yen reflects extraordinary net gains of approximately 470M yen after tax effects, driven predominantly by investment securities sales gains of 663M yen before the impairment loss of 121M yen and other adjustments. Non-operating and extraordinary items combined represent approximately 730M yen or 27% of revenue, with extraordinary gains constituting approximately 2.5% of revenue. The extraordinary component is substantially non-recurring in nature, suggesting that sustainable earnings power centers on the 2.6B yen operating income level rather than the 2.3B yen net income. Operating cash flow data is not available for quarterly periods, preventing direct assessment of cash conversion quality. However, balance sheet indicators show inventory days extending and receivables collection cycles lengthening relative to sales trends, suggesting some deterioration in working capital efficiency that could pressure cash conversion. The substantial increase in investment securities and corresponding valuation gains in other comprehensive income indicate that reported equity includes significant unrealized appreciation subject to market volatility. Core earnings quality based on operating activities appears sound given the 35% operating income improvement, but reported net income includes meaningful non-recurring elements that are unlikely to repeat at current levels.
Full-year guidance targets revenue of 38.0B yen, operating income of 3.5B yen, ordinary income of 3.7B yen, and net income of 2.9B yen. Q3 cumulative progress rates are 70.9% for revenue, 73.9% for operating income, 77.3% for ordinary income, and 78.1% for net income. Against standard expectations of 75% completion at Q3, revenue is tracking 4.1 percentage points behind while profits are running 1 to 3 percentage points ahead of pace. The revenue shortfall of 4.1 percentage points suggests Q4 requires 11.1B yen in sales, representing a 5% sequential increase from the 10.6B yen quarterly average in the first nine months, indicating modest acceleration needed. Operating income tracking 1.1 percentage points below standard pace implies Q4 operating income of approximately 912M yen is needed, compared to the 863M yen quarterly average thus far, representing a 6% sequential improvement requirement. The faster profit progression relative to revenue suggests margin improvement trends continue, with Q4 implied operating margin of approximately 8.2% versus 9.6% YoY in Q3, indicating some moderation expected. The company's full-year net income guidance of 2.9B yen implies Q4 net income of approximately 390M yen, substantially below the 750M yen quarterly average in the first nine months, suggesting guidance conservatively assumes no repetition of Q1-Q3's investment securities gains. YoY guidance indicates revenue growth of 2.9%, operating income growth of 14.9%, and ordinary income growth of 11.4%, all representing meaningful improvement over prior year despite the modest Q3 cumulative revenue decline. No revisions to guidance were announced, suggesting management maintains confidence in full-year targets despite the Q3 revenue progression gap.
Annual dividend of 38 yen per share is forecast for the full year, comprising year-end dividend of 38 yen with no interim distribution. This compares to 36 yen in the prior year, representing a 5.6% increase. Against Q3 cumulative net income of 2.3B yen and estimated outstanding shares yielding full-year net income guidance of 2.9B yen, the payout ratio calculates to approximately 37% based on forecast full-year earnings. At current net income of 2.3B yen for nine months, the annualized payout ratio would be approximately 46% if applying the 38 yen dividend, though this includes non-recurring gains. Against normalized operating earnings, the payout appears sustainable within moderate ranges. Treasury stock holdings increased from 333M yen to 609M yen, an 83% rise representing approximately 276M yen in share repurchases during the period. This repurchase activity combined with dividends suggests total shareholder returns. Estimating total annual dividends of approximately 860M yen based on the 38 yen per share guidance and share count implied by EPS guidance of 125.25 yen, plus the 276M yen in actual repurchases in nine months, indicates total returns of approximately 1.1B yen. Against net income of 2.3B yen YTD, this represents a total return ratio of approximately 50%. The payout ratio of 37% for dividends only remains comfortably sustainable, while the combined total return ratio near 50% reflects balanced capital allocation between shareholder distributions and balance sheet strengthening.
Raw material and chemical product market volatility poses significant risk given Chemistry segment concentration at 57% of revenue, with input cost fluctuations directly impacting profitability margins that improved to 8.6% from 5.3% but remain exposed to commodity price movements and supply chain disruptions. Inventory holdings of 11.2B yen increased 14.3% against declining revenue, creating inventory obsolescence risk with days inventory outstanding extending beyond healthy ranges, particularly concerning given the 121M yen impairment already recorded in the silicon wafer business indicating potential for further write-downs. Short-term debt concentration at 98.1% of total liabilities creates refinancing risk exposure, requiring continuous access to credit markets despite current low absolute debt levels of 3.1B yen and strong interest coverage of 70 times, with any disruption in refinancing capability threatening liquidity given the current ratio dependency on this short-term structure.
[Industry Position] (Reference - Proprietary Analysis)
Profitability metrics show ROE of 5.7% slightly above the manufacturing industry median of 5.2% for Q3 2025, placing the company in line with sector norms though both company and industry levels reflect moderate return profiles warranting improvement. Operating margin of 9.6% exceeds the industry median of 8.7%, representing above-median performance and ranking the company in approximately the 60th percentile, indicating operational efficiency advantages versus peers. Net profit margin of 8.4% substantially exceeds the industry median of 6.4%, placing the company in the upper quartile at approximately the 75th percentile, though this superior positioning partially reflects non-recurring investment gains rather than purely operational performance.
Efficiency indicators reveal asset turnover of 0.455 below the industry median of 0.58, placing the company in the lower quartile and indicating capital intensity challenges or underutilized assets relative to manufacturing peers. This below-median asset efficiency constrains ROE despite superior profit margins. Working capital metrics show receivables turnover days and inventory turnover days both elevated relative to industry standards, with payables turnover also extended, suggesting balanced but slow working capital cycling across the cash conversion cycle.
Financial health metrics indicate an equity ratio of 66.3% above the industry median of 63.8%, reflecting a solid capital foundation in the upper-median range. Current ratio of 163% significantly trails the industry median of 283%, placing the company in the lower quartile for liquidity coverage, primarily due to the short-term debt concentration structure rather than absolute liquidity constraints. Financial leverage of 1.51 aligns closely with the industry median of 1.53, indicating standard capital structure positioning.
Growth metrics show revenue decline of 1.5% underperforming the industry median growth of 2.8%, though the company's profit growth substantially exceeds typical sector performance driven by margin expansion and non-recurring factors. ROIC of 4.6% tracks below the industry median of 6.0%, consistent with the asset turnover challenges and indicating room for capital efficiency improvement to reach peer-level returns.
Overall, the company demonstrates above-average profitability margins offset by below-average asset efficiency, resulting in market-rate ROE. The liquidity structure differs from industry norms with higher short-term debt concentration, while fundamental solvency metrics remain healthy. Capital efficiency improvement represents the primary opportunity to enhance competitive positioning.
(Industry: Manufacturing sector, Comparison: Q3 2025 fiscal periods, n=approximately 100 comparable companies, Source: Proprietary analysis)
Operating performance improvement with 35% operating income growth despite flat revenue demonstrates successful margin expansion and cost management, achieving a 9.6% operating margin that exceeds both prior year performance and industry median levels, suggesting sustainable operational efficiency gains that form a foundation for future earnings power separate from non-recurring items. The Chemistry segment's margin recovery to 8.6% from 5.3% despite revenue decline indicates successful restructuring, though the 121M yen silicon wafer impairment signals ongoing challenges in specific sub-segments requiring continued monitoring of asset productivity and potential for additional write-downs.
Working capital efficiency deterioration with inventory increasing 14% against declining revenue and receivables collection extending creates cash conversion concerns that could constrain the translation of reported earnings into free cash flow, particularly important given the absence of disclosed operating cash flow data and the concentration of 98% of debt in short-term maturities requiring refinancing attention despite low absolute leverage levels. Asset turnover of 0.455 below the industry median of 0.58 combined with ROIC of 4.6% trailing the sector median of 6.0% indicates capital efficiency improvement opportunities through accelerated asset turns or capital redeployment to higher-return activities.
Non-recurring contribution of investment securities sales gains totaling 663M yen represents approximately 29% of reported net income and approximately 190% of the YoY net income increase, indicating that sustainable earnings power centers closer to 1.8B yen normalized net income excluding these gains, suggesting reported 54% net income growth materially overstates underlying business momentum that more accurately reflects the 35% operating income improvement as core earnings trajectory. Investment securities holdings expanding 27% to 11.0B yen or 18.5% of total assets creates valuation sensitivity, with 1.7B yen in unrealized gains recorded in comprehensive income subject to market volatility that could reverse and impact future reported equity levels.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.